|
FY2026
12 months to Apr 30, 2026
|
FY2025
12 months to Apr 30, 2025
|
FY2024
12 months to Apr 30, 2024
|
FY2023
12 months to Apr 30, 2023
|
|
|---|---|---|---|---|
| Operating activities | ||||
| Net loss for the year | ||||
| Items not affecting cash: | ||||
| Amortization | ||||
| Depreciation | ||||
| Share-based compensation | ||||
| Revaluation loss on investment in equity instruments | ||||
| Impairment loss | ||||
| Accounts payable and accrued liabilities | ||||
| Due to related parties | ||||
| Share of gain of associate and deemed disposal gain | ||||
| Gain on debt settlement from of Visla Royalties Corp. | ||||
| Gain on spin out of Visla Royalties Corp. | ||||
| Unrealized gain (loss) on investments at FVTPL | ||||
| Share of income of Vizsla Royalties Corp. | ||||
| Gain on debt settlement from Vizsla Royalties Corp. | ||||
| Income taxes | ||||
| Other receivable | ||||
| Prepaid expenses | ||||
| Gain on spin out of royalty interest | ||||
| Loss on Capped Call Options | ||||
| Revaluation gain on Derivative Liabilities | ||||
| Interest expense on Convertible Note | ||||
| Accretion expense on Convertible Note | ||||
| Changes in working capital items | ||||
| Net cash flows used in operating activities | ||||
| Investing activities | ||||
| Payments for exploration and evaluation assets | ||||
| Deferred payment of exploration and evaluation assets | ||||
| Exploration and evaluation expenditures | ||||
| Accounts payable related to exploration and evaluation assets | ||||
| Payments for property plant and equipment | ||||
| Purchase of capped call derivative options | ||||
| Proceeds from disposals of investments | ||||
| Purchase of investments in equity instruments | ||||
| Purchase of investments in warrants investments | ||||
| Strategic investment expenditures | ||||
| Redemption (Investment) of term deposits | ||||
| Short-term investments in Guaranteed Investment Certificate (“GIC”) | ||||
| Maturity of guaranteed investment certificates | ||||
| Net cash flows used in investing activities | ||||
| Financing activities | ||||
| Common shares proceeds - net of share issuance | ||||
| Proceeds from exercise warrants | ||||
| Proceeds from exercise of stock options | ||||
| Proceeds from convertible notes, net of transaction costs | ||||
| Net cash flows provided by financing activities | ||||
| Effects of foreign exchange | ||||
| Effects of exchange rate changes on cash and cash equivalents | ||||
| Increase in cash and cash equivalents | ||||
| Cash and cash equivalents, beginning of year | ||||
| Cash and cash equivalents, end of year | ||||
| Issuance of common shares for strategic investment | ||||
| Share issuance costs - finders warrants | ||||
| Shares issued for RSUs | ||||
| Shares to be issued for E&E acquisition | ||||
Loading...